BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2963219)

  • 1. Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release.
    Nikolarakis KE; Almeida OF; Herz A
    NIDA Res Monogr; 1986; 75():403-5. PubMed ID: 2963219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (CRF).
    Almeida OF; Nikolarakis KE; Herz A
    NIDA Res Monogr; 1986; 75():401-2. PubMed ID: 2893273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Endorphin modulates the inhibitory action of corticotropin-releasing factor on luteinizing hormone secretion.
    Petraglia F; Vale W; Rivier C
    NIDA Res Monogr; 1986; 75():331-4. PubMed ID: 2893271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
    Rivest S; Plotsky PM; Rivier C
    Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.
    Petraglia F; Sutton S; Vale W; Plotsky P
    Endocrinology; 1987 Mar; 120(3):1083-8. PubMed ID: 3542513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor.
    Almeida OF; Nikolarakis KE; Herz A
    Endocrinology; 1988 Mar; 122(3):1034-41. PubMed ID: 3257730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute immobilization stress and intraventricular injection of CRF suppress naloxone-induced LH release in ovariectomized estrogen-primed rats.
    Akema T; Chiba A; Shinozaki R; Oshida M; Kimura F; Toyoda J
    J Neuroendocrinol; 1996 Aug; 8(8):647-52. PubMed ID: 8866253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by lipopolysaccharide of naloxone-induced luteinising hormone secretion is accompanied by increases in corticotropin-releasing factor immunoreactivity in hypothalamic paraventricular neurones in female rats.
    He D; Akema T
    J Neuroendocrinol; 2005 Feb; 17(2):67-72. PubMed ID: 15796756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
    Karanth S; Lyson K; Aguila MC; McCann SM
    Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.
    Rivier C; Vale W
    Fed Proc; 1985 Jan; 44(1 Pt 2):189-95. PubMed ID: 2981740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and beta-endorphin.
    Lenz HJ
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1417-20. PubMed ID: 2521953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.
    Sirinathsinghji DJ
    Brain Res; 1986 Jun; 375(1):49-56. PubMed ID: 3013371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of corticotrophin-releasing factor and beta-endorphin on LH and FSH secretion in the lactating rat.
    Taya K; Sasamoto S
    J Endocrinol; 1989 Mar; 120(3):509-15. PubMed ID: 2522494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of corticotropin-releasing factor on reproductive functions in the rat.
    Rivier C; Vale W
    Endocrinology; 1984 Mar; 114(3):914-21. PubMed ID: 6321146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine elevates rat plasma ACTH by a central mechanism.
    Matta SG; Beyer HS; McAllen KM; Sharp BM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):217-26. PubMed ID: 2822898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of hypothalamic neuropeptides upon luteinizing hormone secretion by cultured rat anterior pituitary cells.
    Leiva LA; Croxatto HB
    Biol Res; 1994; 27(2):113-21. PubMed ID: 8640240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central activation of thermogenesis by prostaglandins: dependence on CRF.
    Rothwell NJ
    Horm Metab Res; 1990 Dec; 22(12):616-8. PubMed ID: 2076859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of corticotrophin-releasing factor receptor types 1 and 2 in stress-induced suppression of pulsatile luteinising hormone secretion in the female rat.
    Li XF; Bowe JE; Kinsey-Jones JS; Brain SD; Lightman SL; O'Byrne KT
    J Neuroendocrinol; 2006 Aug; 18(8):602-10. PubMed ID: 16867181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V; Rivier J; Wang L; Taché Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF; Thatcher-Britton K
    Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.